OR WAIT null SECS
January 01, 2026
Article
2025 featured multiple advancements in women's health aimed at enhancing treatment options and awareness.
December 30, 2025
Catch up on the most impactful headlines in hormonal disorders from all of 2025 with our Year in Review.
October 08, 2025
The Q3 recap for endocrinology spotlights major FDA decisions, new guidelines for managing diabetes during pregnancy, and major clinical trial updates.
October 07, 2025
Catch up on FDA decisions, critical trial results, and expert perspectives on endocrinology.
August 08, 2025
Discover key advancements in endocrinology from July 2025, including FDA approvals and trial results.
July 21, 2025
Video
Presented at ENDO 2025, crinecerfont exhibited sustained androgen reduction when combined with glucocorticoids.
July 04, 2025
Explore key advancements in endocrinology from Q2 2025, including FDA approvals and groundbreaking diabetes research shaping future treatments.
May 29, 2025
The FDA approves hydrocortisone oral solution for pediatric adrenal insufficiency, enhancing dosing accuracy and ease for young patients and caregivers.
May 06, 2025
Our April 2025 month in review highlights significant advancements in endocrinology, including innovative therapies and FDA approvals that enhance diabetes management.
March 13, 2025
Chronic hypoparathyroidism requires holistic management addressing more than just calcium normalization to achieve optimal patient outcomes.
